Numinus Wellness To Conduct $10.0 Million Bought Deal

Numinus Wellness (TSXV: NUMI) evidently is seeing strong investor demand, with the psychedelics firm this morning announced a $10.0 million bought deal financing lead by Canaccord Genuity and Eight Capital. The financing is to see roughly 14.7 million units of the company sold.

Priced at $0.68 per unit, each unit is to contain one common share of the company along with a half purchase warrant. Each warrant is exercisable at a price of $0.90 per share for a period of two years from the date of issuance.

An over allotment option has also been granted to the underwriters, enabling up to $1.5 million in additional funds to be raised through the sale of 2.2 million more units. The over allotment option is valid for a period of thirty days from closing date.

Proceeds from the financing are said to be split across several items, including upgrading the firms existing lab and equipment to prepare for clinical trials, seeking approval for and commencing compassionate access trials, reviewing and completing potential acquisitions, facilitating R&D of medical protocols and standard operating procedures for psychedelic therapies, potentially build out the existing wellness centre, and finally general working capital purposes.

The financing is expected to close December 29, with the company indicating that it will look to list the associated warrants from trading on the TSX Venture.

Numinus Wellness last traded at $0.78 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Verses Hits Commercialization Stage With Genius AI Platform

Related News

Numinus Sees Integrated VC, MAPS Lead $6.0 Million Funding Round

Numinus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that...

Friday, February 2, 2024, 09:00:02 AM

Numinus Wellness’ Study On MDMA-Assisted Therapy For PTSD Gets Health Canada Nod

Numinus Wellness Inc. (TSXV: NUMI) announced today that it has secured approval from Health Canada...

Monday, July 12, 2021, 09:49:00 AM

Numinus Releases 2020 Operational Objectives

Numinus Wellness (TSXV: NUMI) released its near term 2020 objectives this morning related to its...

Thursday, May 28, 2020, 08:33:29 AM

Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after...

Monday, September 20, 2021, 02:41:00 PM

Numinus Wellness: Hot Damn! I’ve Never Invested In A Psychedelics Company Before!

The marijuana trade hadn’t even fully fallen apart yet when the first mushroom companies started...

Sunday, December 6, 2020, 09:00:00 AM